Evaluation of fatty liver disease self-care applications: a systematic review and evaluation of apps using the mobile application rating scale (MARS) [0.03%]
脂肪肝疾病自我管理应用程序的评价：系统性综述及移动应用评分规则下的综合评估
Niloofar Mohammadzadeh,Amir Hossein Daeechini,Atefeh Paghe et al.
Niloofar Mohammadzadeh et al.
Background: The use of mobile health applications (apps) has a significant impact on lifestyle changes, especially in chronic diseases such as fatty liver disease, and provides a good opportunity for self-care and lifesty...
Short-chain fatty acids of intestinal origin attenuate protein-bound uremic toxins in patients with chronic kidney disease by protecting the intestinal barrier: a pooled analysis of multiple studies with individualized intervention strategies [0.03%]
肠道短链脂肪酸通过保护肠屏障减轻慢性肾脏病患者蛋白结合尿毒症毒素：多项研究的个体化干预策略汇总分析
Mengzhe Wang,Yumeng Li,Zixuan Fu et al.
Mengzhe Wang et al.
Background: Patients with chronic kidney disease (CKD) present a disordered short-chain fatty acid (SCFA)-intestinal barrier-protein-bound uremic toxin (PBUT) axis, while clinical guidelines lack strategies for PBUT sourc...
Preoperative and perioperative predictors of prolonged hospital stay after uncomplicated elective laparoscopic cholecystectomy: a retrospective cohort study [0.03%]
预测选择性腹腔镜胆囊切除术后长时间住院的术前和围手术期指标：回顾性队列研究
Ramazan Topcu,Turker Kaymak,Mahmut Arif Yüksek et al.
Ramazan Topcu et al.
Background: Although laparoscopic cholecystectomy is considered the gold standard for benign gallbladder disease and is typically associated with short hospitalization, a subset of patients experience prolonged length of ...
Changing etiological spectrum of cirrhosis in China: a systematic review and meta-analysis [0.03%]
中国肝硬化病因谱变迁的系统综述和.meta.分析
Cong He,Pengcheng Liu,Xiaoxiang Liu et al.
Cong He et al.
Background: Cirrhosis remains a major public health challenge in China and has historically been driven mainly by chronic viral hepatitis. However, alcohol-related liver disease and metabolic liver disease have received i...
Effectiveness and safety of vedolizumab in real-world studies in Asian patients with inflammatory bowel disease: a systematic review and meta-analysis [0.03%]
vedolizumab在亚洲炎症性肠病患者中真实世界研究的有效性和安全性：系统评价和meta分析
Yubei Gu,Xiaoyan Zhang,Lifei Gu et al.
Yubei Gu et al.
Background: To evaluate the real-world effectiveness and safety of vedolizumab (VDZ) in Asian patients with IBD, including Crohn's disease (CD) and Ulcerative colitis (UC). ...
Associations of bilirubin, albumin, and the ALBI index with gastric cancer risk: a smoking-stratified prospective cohort study in men [0.03%]
血清胆红素、白蛋白及ALBI指数与胃癌发病风险的关联：一项针对男性吸烟分层的前瞻性队列研究
Jong Won Shin,Ji-Won Lee,Nguyen Thien Minh et al.
Jong Won Shin et al.
Background: Bilirubin and albumin are endogenous antioxidants, and the ALBI index may reflect systemic oxidative stress. However, their associations with gastric cancer risk, especially by smoking status in healthy popula...
Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort [0.03%]
2012年至2019年期间瑞士用于治疗炎症性肠病的妊娠前后用药情况：基于MAMA队列的研究
Eva Gerbier,Nazanin Abolhassani,Marc Dupuis et al.
Eva Gerbier et al.
Background: Effective management of Inflammatory bowel diseases (IBD) before and during pregnancy is crucial as women with well-controlled IBD at conception tend to remain in remission throughout pregnancy, experiencing o...
Machine learning models to predict the recurrence of common bile duct stones after ERCP [0.03%]
内镜乳头括约肌切开术后胆总管结石复发的预测模型研究
Xu Han,Mujie Ye,Ye Tian et al.
Xu Han et al.
Objective: To construct predictive models for the recurrence of common bile duct stones (CBDS) following endoscopic retrograde cholangiopancreatography (ERCP). ...
TACE, lenvatinib, and PD-1 inhibitors in unresectable advanced hepatocellular carcinoma: an exploratory retrospective cohort study [0.03%]
不可切除的晚期肝细胞癌患者中经动脉化疗栓塞、仑伐替尼及PD-1抑制剂的使用：一项探索性回顾队列研究
Hongyi Zhao,Tingting Li,Yu Zhang et al.
Hongyi Zhao et al.
Background: For patients with unresectable advanced hepatocellular carcinoma (HCC), therapeutic options are limited, and transarterial chemoembolization (TACE) alone often yields suboptimal outcomes. This study aimed to e...
Outcomes for a digital prescription mobile application for adults with irritable bowel syndrome: an uncontrolled trial [0.03%]
成人 Irritable Bowel Syndrome 数字化处方手机应用程序效果未控试验结果分析
Mohsin F Butt,Maiss Reghefaoui,Debbie Bush et al.
Mohsin F Butt et al.
Background: Behavioral therapies are effective in the management of irritable bowel syndrome (IBS). Mahana™ IBS is a mobile phone application designed to deliver 10 sessions (10-12 weeks) of gut-directed cognitive behavi...